BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8661817)

  • 1. Treatment of liver metastases of carcinoid tumors.
    Ahlman H; Westberg G; Wängberg B; Nilsson O; Tylén U; Scherstén T; Tisell LE
    World J Surg; 1996 Feb; 20(2):196-202. PubMed ID: 8661817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.
    Wängberg B; Westberg G; Tylén U; Tisell L; Jansson S; Nilsson O; Johansson V; Scherstén T; Ahlman H
    World J Surg; 1996 Sep; 20(7):892-9; discussion 899. PubMed ID: 8678968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of disseminated midgut carcinoid tumours.
    Ahlman H; Wängberg B; Jansson S; Stenqvist O; Geterud K; Tylén U; Caidahl K; Scherstén T; Tisell LE
    Digestion; 1991; 49(2):78-96. PubMed ID: 1724766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryosurgical debulking of unresectable liver metastases for palliation of carcinoid syndrome.
    Johnson LB; Krebs T; Wong-You-Cheong J; Njoku M; Plotkin JS; Daly B; Wilson S; Kuo PC
    Surgery; 1997 Apr; 121(4):468-70. PubMed ID: 9122880
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical treatment of carcinoid tumours of the stomach and small intestine.
    Ahlman H
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S198-201. PubMed ID: 10604130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdominal surgery in patients with midgut carcinoid tumors.
    Akerström G; Makridis C; Johansson H
    Acta Oncol; 1991; 30(4):547-53. PubMed ID: 1854512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative management strategies of advanced gastrointestinal carcinoid neoplasms.
    Sartori P; Mussi C; Angelini C; Crippa S; Caprotti R; Uggeri F
    Langenbecks Arch Surg; 2005 Sep; 390(5):391-6. PubMed ID: 15968542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelfoam powder embolization of the hepatic artery in liver metastases of carcinoid tumors.
    Lunderquist A; Ericsson M; Nobin A; Sandén G
    Radiologe; 1982 Feb; 22(2):65-70. PubMed ID: 7071325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
    Strosberg JR; Choi J; Cantor AB; Kvols LK
    Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary.
    Norton JA; Kerlan RK
    Cancer J; 2003; 9(4):241-3. PubMed ID: 12967132
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic, surgical and medical aspect of the midgut carcinoids.
    de Vries H; Verschueren RC; Willemse PH; Kema IP; de Vries EG
    Cancer Treat Rev; 2002 Feb; 28(1):11-25. PubMed ID: 12027412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment of carcinoid syndrome in two cases of bronchial carcinoid].
    Katakami N; Matsumoto H; Ishihara K; Umeda B
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1313-8. PubMed ID: 8583728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors.
    Makridis C; Rastad J; Oberg K; Akerström G
    World J Surg; 1996 Sep; 20(7):900-6; discussion 907. PubMed ID: 8678969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
    Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
    Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic dearterialization for carcinoid syndrome due to liver metastases.
    Idema AA; Niermeyer P; Oldhoff J
    Arch Chir Neerl; 1977; 29(2):125-33. PubMed ID: 900958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for metastatic carcinoid tumors.
    Frilling A; Rogiers X; Knöfel WT; Broelsch CE
    Digestion; 1994; 55 Suppl 3():104-6. PubMed ID: 7698531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality treatment for gastric carcinoid tumor with liver metastases.
    Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
    Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.
    Schell SR; Camp ER; Caridi JG; Hawkins IF
    J Gastrointest Surg; 2002; 6(5):664-70. PubMed ID: 12399054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
    Massimino K; Harrskog O; Pommier S; Pommier R
    J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation treatment of refractory carcinoid hepatic metastases.
    Wessels FJ; Schell SR
    J Surg Res; 2001 Jan; 95(1):8-12. PubMed ID: 11120628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.